Neurotransmitters—key factors in neurological and neurodegenerative disorders of the central nervous system

RI Teleanu, AG Niculescu, E Roza… - International journal of …, 2022 - mdpi.com
Neurotransmitters are molecules that amplify, transmit, and convert signals in cells, having
an essential role in information transmission throughout the nervous system. Hundreds of …

Astrocyte contribution to dysfunction, risk and progression in neurodegenerative disorders

AN Brandebura, A Paumier, TS Onur… - Nature Reviews …, 2023 - nature.com
There is increasing appreciation that non-neuronal cells contribute to the initiation,
progression and pathology of diverse neurodegenerative disorders. This Review focuses on …

The biology and pathobiology of glutamatergic, cholinergic, and dopaminergic signaling in the aging brain

A Gasiorowska, M Wydrych, P Drapich… - Frontiers in aging …, 2021 - frontiersin.org
The elderly population is growing worldwide, with important health and socioeconomic
implications. Clinical and experimental studies on aging have uncovered numerous …

Parkinson's disease risk and hyperhomocysteinemia: the possible link

HM Al-Kuraishy, AI Al-Gareeb, YHA Elewa… - Cellular and Molecular …, 2023 - Springer
Parkinson's disease (PD) is one of the most common degenerative brain disorders caused
by the loss of dopaminergic neurons in the substantia nigra (SN). Lewy bodies and …

Astrocytic glutamatergic transmission and its implications in neurodegenerative disorders

S Satarker, SL Bojja, PC Gurram, J Mudgal, D Arora… - Cells, 2022 - mdpi.com
Several neurodegenerative disorders involve impaired neurotransmission, and
glutamatergic neurotransmission sets a prototypical example. Glutamate is a predominant …

Toluene toxicity in the brain: from cellular targets to molecular mechanisms

AA Shaw, JD Steketee, AN Bukiya… - Annual Review of …, 2025 - annualreviews.org
Toluene intoxication constitutes a persistent public health problem worldwide. While most
organs can be damaged, the brain is a primary target whether exposure is accidental …

NF‐κB/NLRP3 inflammasome axis and risk of Parkinson's disease in Type 2 diabetes mellitus: A narrative review and new perspective

M Alrouji, HM Al‐kuraishy, AI Al‐Gareeb… - Journal of Cellular …, 2023 - Wiley Online Library
Parkinson's disease (PD) is the second most common neurodegenerative disease after
Alzheimer's disease (AD). Genetic predisposition and immune dysfunction are involved in …

[HTML][HTML] Striatal glutamatergic hyperactivity in Parkinson's disease

F Campanelli, G Natale, G Marino, V Ghiglieri… - Neurobiology of …, 2022 - Elsevier
Glutamatergic hyperactivity in the nucleus striatum, the main basal ganglia input, has been
involved in the progression of Parkinson's disease (PD) and the onset of L-Dopa-induced …

Neuroprotective function of high glycolytic activity in astrocytes: common roles in stroke and neurodegenerative diseases

S Takahashi - International Journal of Molecular Sciences, 2021 - mdpi.com
Astrocytes (also, astroglia) consume huge amounts of glucose and produce lactate
regardless of sufficient oxygen availability, indicating a high capacity for aerobic glycolysis …

Emerging evidence for the widespread role of glutamatergic dysfunction in neuropsychiatric diseases

T McGrath, R Baskerville, M Rogero, L Castell - Nutrients, 2022 - mdpi.com
The monoamine model of depression has long formed the basis of drug development but
fails to explain treatment resistance or associations with stress or inflammation. Recent …